Bupropion in the treatment of depression in Parkinson's disease

International Psychogeriatrics

Volumn 23, Issue 2, 2011, Pages 325-327

  Załuska, Maria ^a   Dyduch, Agnieszka ^b  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b BIELANSKI HOSPITAL   (Poland)

Author keywords

depressive symptoms; extrapyramidal syndrome; pharmacotherapy

Indexed keywords

ACENOCOUMAROL; AMFEBUTAMONE; BENSERAZIDE; DOXEPIN; FLUOXETINE; FUROSEMIDE; IMIPRAMINE; LEVODOPA; METOPROLOL; MIANSERIN; PIRACETAM; RAMIPRIL; RISPERIDONE; SIMVASTATIN; SPIRONOLACTONE; SULPIRIDE; ANTIDEPRESSANT AGENT;

AGED; APATHY; ARTICLE; CASE REPORT; DEPRESSION; DRUG WITHDRAWAL; FEMALE; HUMAN; INSOMNIA; IRRITABILITY; MOTOR PERFORMANCE; PARKINSON DISEASE; SUICIDAL IDEATION; UNIFIED PARKINSON DISEASE RATING SCALE; VISUAL HALLUCINATION; BRAIN; COMPUTER ASSISTED TOMOGRAPHY; PATHOLOGY; PSYCHOLOGICAL ASPECT;

AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BRAIN; BUPROPION; DEPRESSIVE DISORDER; FEMALE; HUMANS; PARKINSON DISEASE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84855473768     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610210001687     Document Type: Article

References (12)

1. Bailey, J. and Waters, S. (2008). Acute psychosis after bupropion treatment in a healthy 28-year-old woman. Journal of the American Board of Family Medicine, 21, 244-245. doi: 10.3122/jabfm.2008.03.070236.
2. Brommelhoff, J. A., Gatz, M., Johansson, B., McArdle, J. J., Fratiglioni, L. and Pedersen, N. L. (2009). Depression as a risk factor or prodromal feature for dementia? Findings in a population-based sample of Swedish twins. Psychology and Aging, 24, 373-384. doi: 10.1037/a0015713.
3. Gebhardt, S., R̈ottgers, H., B̈acker, A., Schu, U. and Krieg, J. C. (2008). Treatment of panic disorder with bupropion in a patient with Parkinson's disease. Journal of Clinical Pharmacy and Therapeutics, 33, 575-577. doi: 10.1111/j.1365-2710.2008.00952.x.
4. Ghazi-Noori, S., Chung, T. H., Deane, K., Rickards, H. E. and Clarke, C. E. (2009). Therapies for depression in Parkinson's disease. Cochrane Database of Systematic Reviews, 4, 1-19. doi: 10.1002/14651858.CD003465.
5. Goetz, C. G., Tanner, C. M. and Klawans, H. L. (1984). Bupropion in Parkinson's disease. Neurology, 34, 1092-1094.
6. Grandas, F. and Ĺopez-Manzanares, L. (2007). Bupropion-induced parkinsonism. Movement Disorders, 22, 1830-1831. doi: 10.1002/mds.21425.
7. Karasu, T. B., Gelenberg, A., Merriam, A. and Wang, P. (2000). Practice Guideline for the Treatment of Patients with Major Depressive Disorder, 2nd edn. Washington, DC: American Psychiatric Association. doi: 10.1176/appi. books.9780890423363.48690.
8. Leentjens, A. F., Verhey, F. R. and Vreeling, F. W. (2000). Een depressieve patïente met de ziekte van Parkinson succesvol behandeld met bupropion. [Successful treatment of depression in a Parkinson disease patient with bupropion.] Nederlands Tijdschrift voor Geneeskunde, 144, 2157-2159.
9. Remy, P., Doder, M., Lees, A., Turjanski, N. and Brooks, D. (2005). Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain, 128, 1314-1322. doi: 10.1093/brain/awh445.
10. Shiba, M. et al. (2000). Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Movement Disorders, 15, 669-677.
11. Stein, W. M. and Read, S. (1997). Chronic pain in the setting of Parkinson's disease and depression. Journal of Pain and Symptom Management, 14, 255-258. doi: 10.1016/S0885-3924(97)00176-0.
12. Veazey, C., Aki, S. O., Cook, K. F., Lai, E. C. and Kunik, M. E. (2005). Prevalence and treatment of depression in Parkinson's disease. Journal of Neuropsychiatry and Clinical Neurosciences, 17, 310-323. doi: 10.1176/appi.neuropsych. 17.3.310.